Koers Miravant Medical Technologies Inc. Other OTC
Aandelen
MRVT
US6046901079
Biotechnologie & Medisch Onderzoek
Omzet 2003 | - | Omzet 2004 | - | Marktkapitalisatie | 36,86 mln. 33,88 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2003 | -7 mln. -6,43 mln. | Nettowinst (verlies) 2004 | -15 mln. -13,79 mln. | EV/omzet 2003 | - |
Nettoschuld 2003 | 11,89 mln. 10,92 mln. | Nettoschuld 2004 | 4,22 mln. 3,88 mln. | EV/omzet 2004 | - |
K/w-verhouding 2003 |
-4,24
x | K/w-verhouding 2004 |
-2,1
x | Werknemers | - |
Dividendrendement 2003 * |
-
| Dividendrendement 2004 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,76% | 111 mld. | |
+11,24% | 106 mld. | |
-12,35% | 22,24 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,61% | 16,81 mld. | |
+38,91% | 12,54 mld. | |
-24,32% | 8,09 mld. |